Stress impairs the ability of macrophages to clear dead cells from allergic lesions, worsening skin symptoms, new research suggests.
More specifically, accumulated dead cells induce the expression of eosinophil-recruiting protein, CCL24, in the skin lesions. CCL24 production is dependent on the caspase-1 enzyme; thus, inhibiting caspase-1 can mitigate and even reverse allergy symptoms, the study authors report.
Recent studies using a mouse model of immunoglobulin E (IgE)-mediated cutaneous allergic inflammation (IgE-CAI) suggest that stress may disrupt immune functions, thereby worsening allergic symptoms by interfering with the body’s inflammatory responses.
In a recent study, a research group led by Associate Professor Soichiro Yoshikawa, Professor Kenji Takamori, and Professor Sachiko Miyake from the Juntendo University Graduate School of Medicine, along with Dr. Hitoshi Urakami and Professor Shin Morizane from the Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, explored the link between stress and allergic symptoms.
The study showed that psychological stress reduces the ability of anti-inflammatory programmed death ligand 2 (PD-L2)-positive macrophages to clear dead cells at the allergy site, thereby exacerbating skin allergy symptoms.
“This study is the first in the world to demonstrate that stress, through the sympathetic nervous system, disrupts macrophage function, which normally helps suppress allergic reactions, thereby intensifying allergic responses,”explains Dr. Yoshikawa in a news release..
To investigate the mechanism linking stress to skin allergies, the researchers used a mouse model, IgE-CAI, where injection of IgE caused persistent ear inflammation. The team first identified the neural tissue involved in IgE-CAI and then investigated the immune cells and factors contributing to the condition. They discovered that psychological stress was linked to a decrease in gene expression in macrophages responsible for clearing dead cells, a process known as efferocytosis. Additionally, they found that the accumulation of dead cells in the lesions led to increased infiltration of eosinophils, worsening the allergic response.
PD-L2-positive macrophages play a key role in maintaining anti-inflammatory functions by removing dead cells. However, the study reveals that psychological stress affects their function by disrupting the activity of the β2-adrenergic receptor (Adrb2) activity. Macrophages that mature under this altered Adrb2 signaling show a reduced ability to perform efferocytosis, leading to worsened skin allergies.
“Our findings suggest that the impact of psychological stress on immune cells is long-lasting and can even affect macrophages that differentiate later. This phenomenon, referred to as ‘stress memory,’ implies that severe stress leaves a lingering imprint on immune cells, influencing their function and contributing to disease development,” says Dr. Yoshikawa.
The study further revealed that the accumulation of dead cells at the lesion site induced the expression of CCL24, contributing to the worsening of skin allergies. However, this expression was found to be dependent on caspase-1 enzyme activity. Administering a caspase-1 inhibitor reduced ear swelling caused by IgE-CAI and reversed eosinophil infiltration at the lesion site, suggesting that caspase-1 inhibitors and agents targeting CCL24 gene expression may be promising approaches for reducing skin allergies, the authors note.
“Anti-inflammatory macrophages play crucial roles in various diseases, including cancer, autoimmune disorders, and wound healing. This study not only sheds light on the impact of stress on allergic inflammation but also lays the groundwork for exploring how stress exacerbates other diseases involving these macrophages,” explains Dr. Yoshikawa.
While avoiding stress altogether would be the ideal solution to prevent immune cell dysfunction, understanding the molecular mechanisms behind stress memory could pave the way for therapeutic strategies that alleviate or reverse these effects. Such advances could lead to novel treatments for stress-related diseases and have broad implications in clinical research.
The study is published online in The Journal of Allergy and Clinical Immunology.
